PubMed · 1985 · 10 citations · 0 references
MedicineHematologyPharmacologyHematopathologyAnemiaHematologic DisordersHematologic ToxicityHematologic Toxicity ManagementHematopoietic ToxicityAcute Hematologic ToxicityDelayed Hematologic ToxicityDose-limiting Hematologic ToxicityDrug-induced Hematologic ToxicityDrug-induced HematotoxicityHematologic Adverse EventsHematologic Toxicity AssessmentHematologic Toxicity Monitoring
Marked leukopenia and/or thrombocytopenia occurred in 12 of 1333 patients treated with aminoglutethimide (0.9% incidence). Depression of blood cell counts was evident within 7 weeks of starting treatment. No delayed toxicity was encountered. Blood cell counts recovered promptly upon cessation of aminoglutethimide in all but one patient, who died from septicemia and marrow aplasia.